BMO Capital initiated coverage of Morgan Stanley (MS) with an Outperform rating and $180 price target The company appears a high-quality, less-cyclical play on deregulation, with meaningful upside from a capital markets recovery, the analyst tells investors in a research note. While valuation levels are challenging, the combination of deregulation benefits and incremental net new asset growth from a capital markets recovery provide a compelling case for upside potential, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MS:
- ‘Strong Turnaround’? Nike Stock (NKE) Races on Q1 Beat, But Analyst Forecasts Fracture
- Morgan Stanley makes statement on Stress Capital Buffer reconsideration
- Morgan Stanley price target raised to $165 from $150 at Evercore ISI
- Upcoming IPO Alert! Beta Technologies and Ethos Gear Up for U.S. Market Debuts
- Crypto Currents: SEC clears path for altcoin ETFs as SWIFT plans blockchain